Bank of America Corporation (BAC) vs Eli Lilly and Company (LLY)

Bank of America Corporation is one of the largest U.S. financial institutions, with a $3.5 trillion balance sheet and the second-largest deposit market share in the country, underscoring its central role in the American economy. The company has preserved a strong position among domestic middle-market and retail customers while also maintaining a significant international presence, supported by the world’s fourth-largest trading operation and an investment banking business that consistently ranks among the top four in global league tables. Bank of America operates through four main segments: consumer banking, global wealth and investment management, global banking, and global markets.

Eli Lilly & Co. is a pharmaceutical company focused on neuroscience, cardiometabolic disease, oncology, and immunology. Its leading products include Verzenio and Jaypirca in cancer treatment; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin in cardiometabolic care; and Taltz and Olumiant in immunology.